Patents by Inventor Corinne Cayrol-Girard

Corinne Cayrol-Girard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for increasing granulocyte number in a patient by administering superactive IL-33 fragments
    Patent number: 9611307
    Abstract: The present invention discloses novel active polypeptide fragments of human IL-33 corresponding to natural forms generated by the proteases of human neutrophils (cathepsin G, elastase 2, proteinase 3), as well as the use thereof as a drug, in particular for the treatment of infectious diseases, inflammatory diseases, atherosclerosis, cardiovascular diseases, obesity, or cancer.
    Type: Grant
    Filed: February 24, 2012
    Date of Patent: April 4, 2017
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Jean-Philippe Girard, Corinne Cayrol-Girard, Emma Lefrancais
  • METHOD FOR INDUCING IL-2-FREE PROLIFERATION OF GAMMA DELTA T CELLS
    Publication number: 20150259645
    Abstract: The present invention concerns a method of inducing IL-2-free proliferation of ?? T cells using a combination of a ?? T cell activator and IL-33 for use in therapy of infection, cancer, autoimmunity as well as other diseases.
    Type: Application
    Filed: November 8, 2013
    Publication date: September 17, 2015
    Applicants: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITÉ PAUL SABATIER TOULOUSE III
    Inventors: Mary Poupot, Jean-Jacques Fournie, Caroline Duault, Jean-Philippe Girard, Corinne Cayrol-Girard
  • Novel Superactive IL-33 Fragments, and Uses Thereof
    Publication number: 20140099280
    Abstract: The present invention discloses novel active polypeptide fragments of human IL-33 corresponding to natural forms generated by the proteases of human neutrophils (cathepsin G, elastase 2, proteinase 3), as well as the use thereof as a drug, in particular for the treatment of infectious diseases, inflammatory diseases, atherosclerosis, cardiovascular diseases, obesity, or cancer.
    Type: Application
    Filed: February 24, 2012
    Publication date: April 10, 2014
    Applicant: Cenre National De La Recherche Scientifique
    Inventors: Jean-Philippe Girard, Corinne Cayrol-Girard, Emma Lefraancais